Heidi raises $65m to cut clinical admin, now valued at $465m
Melbourne-based Heidi, a healthcare AI startup, has closed a USD $65 million Series B led by Point72 Private Investments, with participation from Blackbird, Headline, and LocalGlobe. The round puts Heidi at a USD $465 million valuation and lifts total funding to nearly $100 million.
Heidi builds AI tools that automate clinician administrative work: drafting documentation, searching evidence, and sending follow-up communications. The company reports its platform is used weekly in over 2 million patient consults across 116 countries and 110 languages.
Expansion plan
The new capital will support hiring and market growth.
- Primary focus: United States, United Kingdom, Canada
- Supporting adoption: France, Spain, Germany, Ireland, South Africa, Singapore, Hong Kong
Why this matters for healthcare leaders
- Reduce note-taking time and after-hours charting, freeing capacity for patient care.
- Standardize documentation quality to support billing and clinical audits.
- Lower clinician burnout driven by EHR workflows and administrative load.
- Multilingual support (110+ languages) can improve access and accuracy in diverse settings.
What to validate before a pilot
- Privacy and security: PHI handling, data retention, encryption, audit trails; compliance with HIPAA and GDPR.
- Integration: EHR compatibility (Epic, Cerner, Meditech), single sign-on, and fit at the point of care.
- Accuracy: performance across accents, specialties, and encounter types; human-in-the-loop controls.
- Clinical governance: redlining process, version history, and accountability for final notes.
- ROI: baseline time-per-note, after-hours charting, and documentation-related denials; target measurable improvements within 4-8 weeks.
Operational impact to watch
- Throughput: shorter encounters without quality loss; reduced backlog.
- Patient experience: more face time, less typing.
- Workforce: recruitment and retention benefits if administrative burden drops.
- Quality: clearer, structured notes that improve coding and handovers.
Heidi's reported adoption-2 million consults weekly across 116 countries-suggests traction at scale. For systems evaluating AI scribes, move from demos to controlled trials with defined metrics and a clear change-management plan.
Lead investor details: Point72 Private Investments. For privacy requirements, review HIPAA guidance (HHS).
If your team is building AI skills to support deployment and governance, see role-based programs at Complete AI Training.
Key facts
- Funding: USD $65 million Series B
- Valuation: USD $465 million
- Total funding to date: ~USD $100 million
- Product: AI for clinical documentation, evidence search, and follow-up messaging
- Usage: 2M+ consults weekly, 116 countries, 110 languages
- Expansion: US, UK, Canada; supporting France, Spain, Germany, Ireland, South Africa, Singapore, Hong Kong
Source: Heidi
Enjoy Ad-Free Experience
Your membership also unlocks:
